Answers are grounded in this paper and cite their sources.
Synaptic vesicle glycoprotein 2A (SV2A) is a critical biomarker for evaluating synaptic density in neurological research. Among available radioligands, [18F]SynVesT-1 is increasingly used in PET research because of its extended half-life, while having comparable pharmacokinetic properties to the widely used [11C]UCB-J. However, quantitative application in rat models remains unexplored for [18F]SynVesT-1. This study aims to validate quantitative kinetic modelling methods for [18F]SynVesT-1 and develop non-invasive quantification methods for synaptic density in rats. First, blood analysis of [18F]SynVesT-1 was performed to generate metabolite-corrected plasma input functions. Then, kinetic modelling was evaluated using compartmental analysis approaches, as well as Logan plot. Furthermore, non-invasive image-derived input functions (IDIF), with and without non-negative matrix factorization (NMF) were compared against the arterial input function (AIF). Blood analysis showed that the parent fraction of the tracer decreased over time following a sigmoid curve, while the plasma-to-whole blood ratio remained stable over time (0.89 ± 0.02). The two-tissue compartmental model (2TCM) and Logan plot were determined to be the most accurate methods for quantification of [18F]SynVesT-1 kinetics in rats. Additionally, the results demonstrated strong agreement between AIF-derived and image-derived volume of distribution (VT) values, with both image-derived input approaches (IDIF and IDIF-NMF) performing equally well. These findings validate kinetic modelling methods for [18F]SynVesT-1 PET, enabling their application in further rat studies for preclinical neuroscience research and prove that image-derived input functions are reliable non-invasive alternatives to AIF.
No takes yet. Share an insight, caveat, or question.
Berckmans et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: